Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Chiron Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
After 200 years of practice, vaccinology has gained new perspectives for preventing infectious diseases. Sequencing of complete bacterial genomes led to the development of new large-scale technologies, such as bioinformatics, proteomics and DNA microarrays. By examining genetic content, as well as transcription and expression profiles, a more detailed understanding of bacterial pathogenesis can be reached. Moreover, the whole-genome perspective is expected to provide an instrumental contribution to vaccine development, particularly to target those pathogens for which the traditional approaches have failed so far. In this review, we describe how genomic approaches can be used to identify novel vaccine candidates or create safer live-attenuated vaccines.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on